Life Sciences

Who is a Foreign Official? Recent FCPA Litigation Sheds New Light
Dulce J. Foster, May 12, 2011

Practical Antitrust Considerations for Combinations in Life Sciences Industries
Adam J. Miller, January 12, 2011

Individuals Face Greater Risks in FDA Cases
Robert J. Klepinski & Dulce J. Foster, November 19, 2010

Over $1 Billion Available in Federal Tax Credits and Grants for Life Science Companies
Jessica D. Manivasager & John S. Parzych, June 18, 2010

If a Movie Star Recommends it, it Must be Good, Right?
Robert J. Klepinski & Ann M. Ladd, September/October 2009
As it appeared in Update Magazine, 2009, Issue 5 (with permission from FDLI)

Privacy Basics: A Quick HIPAA Check for Medical Device Companies
Robert J. Klepinski, August 2009
As it appeared in MD&DI

FDA Releases Draft Guidance on Risk Information in Advertising
Robert J. Klepinski, May 29, 2009

FDA To Address Remaining Pre-Amendments Class III Devices
April 10, 2009

Patent Reform 2009 Submitted to Congress
Mia E. Mendoza, March 10, 2009

Life Sciences and the Stimulus Act - Part I: Promotion of Health Information Technology
Ann M. Ladd, Ryan S. Johnson & Katherine J. Douglas, March 6, 2009

Life Sciences and the Stimulus Act - Part II: Changes to HIPAA Privacy and Security Standards
Ann M. Ladd, Ryan S. Johnson & Katherine J. Douglas, March 6, 2009